» Articles » PMID: 17203489

Transplantation of Immortalized Mesencephalic Progenitors (CSM14.1 Cells) into the Neonatal Parkinsonian Rat Caudate Putamen

Overview
Journal J Neurosci Res
Specialty Neurology
Date 2007 Jan 5
PMID 17203489
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The present study analyzed whether grafts of the mesencephalic progenitor cell line CSM14.1 into the neonatal rat caudate putamen (CPu) differentiate into neurons and whether this is accompanied by a functional improvement in 6-hydroxydopamine (6-OHDA)-lesioned animals. As in previous studies, a neuronal differentiation of CSM14.1 cells transplanted into the CPu of adult animals could not be observed, so we here used neonatal rats, because graft location and host age seemingly are crucial parameters for neural transplant differentiation and integration. Rats bilaterally lesioned at postnatal day 1 by intraventricular 6-OHDA-injections 2 days later received 100,000 CSM14.1 cells prelabelled with the fluorescent dye PKH26 into the right CPu. Five weeks after grafting, the cylinder test was performed, and the data compared with data from age-matched intact controls and bilaterally lesioned-only animals. Brain slices immunostained for tyrosine hydroxylase (TH) were quantified by optical densitometry. We observed a significant preference of left forelimb use exclusively in transplanted animals. In these rats, TH-containing perikarya were found in the grafted CPu, presumedly leading to the significant increase of TH-immunoreactive fibers in this region. Moreover, confocal laser microscopy revealed a differentiation of transplanted PKH26-labelled CSM14.1 cells into neuronal nuclei antigen or TH-immunoreactive cells. Thus, CSM14.1 cells differentiate into TH-containing neurons, which most probably contribute to the preferred forelimb use, indicating a functional integration of CSM14.1 cells into the host basal ganglia loops during early postnatal development. These findings that are in contrast to observations in adult rats suggest instructive cues for neuronal differentiation and integration given by the neonatal microenvironment.

Citing Articles

Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson's disease.

Zhang L, Yang H Mol Biol Rep. 2024; 51(1):347.

PMID: 38400887 DOI: 10.1007/s11033-024-09294-y.


The Crucial Roles of Pitx3 in Midbrain Dopaminergic Neuron Development and Parkinson's Disease-Associated Neurodegeneration.

Wang X, Chen X, Liu G, Cai H, Le W Int J Mol Sci. 2023; 24(10).

PMID: 37239960 PMC: 10218497. DOI: 10.3390/ijms24108614.


Roles of Transcription Factors in the Development and Reprogramming of the Dopaminergic Neurons.

Tian L, Al-Nusaif M, Chen X, Li S, Le W Int J Mol Sci. 2022; 23(2).

PMID: 35055043 PMC: 8775916. DOI: 10.3390/ijms23020845.


Nurr1 promotes neurogenesis of dopaminergic neuron and represses inflammatory factors in the transwell coculture system of neural stem cells and microglia.

Chen X, Qian Y, Wang X, Tang Z, Xu J, Lin H CNS Neurosci Ther. 2018; 24(9):790-800.

PMID: 29450981 PMC: 6489950. DOI: 10.1111/cns.12825.


The proteome of the differentiating mesencephalic progenitor cell line CSM14.1 in vitro.

Weiss B, Haas S, Lessner G, Mikkat S, Kreutzer M, Glocker M Biomed Res Int. 2014; 2014:351821.

PMID: 24592386 PMC: 3925624. DOI: 10.1155/2014/351821.